You searched for "Emergency"

1769 results found

The increased use of surgical adjuncts in complex cataract surgeries undertaken in the COVID-19 pandemic

The authors explore whether more complicated cataract operations have been performed in the NHS since the start of the coronavirus pandemic. Restrictions in availability of access to elective cataract surgery during the COVID-19 pandemic and subsequent case prioritisation based on...

Intravitreal Aflibercept (IVT-AFL): treatment of macular oedema secondary to RVO

This paper is a sub-group analysis of the real-world effectiveness, treatment patterns, and safety of IVT-AFL in patients with macular oedema secondary to retinal vein occlusion (RVO) in Italy. One hundred and fifity-two treatment-naïve and 50 pretreated patients were enrolled...

IVT Aflibercept 2mg in nAMD: XTEND at 3 years

This study investigated the long-term, effectiveness and safety of IVT-AFL 2mg for neovascular age-related macular degeneration (nAMD). XTEND was a multicentre, observational, prospective study, which was conducted across 127 centres across 17 countries with a follow-up period of 36 months....

Virtual ophthalmic conferences: learnings from the Covid-19 pandemic

The Covid-19 pandemic was the catalyst for a number of paradigm shifts in numerous industries. The demand for proxies that follow social distancing measures created a hotbed for digital solutions and transitioned these to social convention. In the aftermath, the...

The screening and treatment of retinopathy of prematurity

A male child is born at 31 weeks and requires 100% oxygen supplementation with intensive care. What would be the ophthalmic management of this child? In the first instance, it will be useful to know the screening criteria and protocol....

The role of inflammation in the pathophysiology of DMO

Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...

IN FOCUS - The achievements and lasting effects of VISION 2020

Blindness is a major public health problem globally. The first estimate of global blindness by the World Health Organization (WHO) in 1972 provided a figure of 10 to 15 million, which was considered an underestimate [1]. In 1999, an extraordinary...

From trainee to teacher: Top tips for teaching fellow applications

Getting into ophthalmology training has become increasingly competitive in recent years. In 2025, the competition ratio rose to over 21:1, compared to 3:1 in 2019 [1,2]. Similar trends are seen across other specialties, with over 30,000 doctors applying for just...

What’s new in wet AMD papers?

Paper presentations on neovascular (‘wet’) age-related macular degeneration (AMD) from the 16th European Society of Retina Specialists Congress, Copenhagen, September 2016, outline recent research directions evaluating the impact of vision loss on key health domains, patient preferences in the process...

Introduction of the Mydriasert insert at the Manchester Royal Eye Hospital

The authors report on a study to examine the effects of the Mydriasert insert on time, effects, patient comfort and tolerability at Manchester Royal Eye Hospital. Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to ophthalmic surgery, which...

VISION 2020 LINKS Programme: the Madagascar-Leeds LINK

Madagascar is a fascinating and culturally rich island which has an ‘exotic’ status in most people’s eyes. Yet it is among the poorest countries in the world. According to the World Bank, 92% of the population live on less than...

My ophthalmic elective: Harvard Medical School

Medical electives are an excellent opportunity to learn, enjoy and explore countries and their healthcare systems. I was grateful to do mine in ophthalmology at Harvard Medical School (HMS). This article will share my personal experience working at HMS with...